[HTML][HTML] Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach
Cancer immunotherapy has gained traction in recent years owing to remarkable tumor
clearance in some patients. Despite the notable success of immune checkpoint blockade …
clearance in some patients. Despite the notable success of immune checkpoint blockade …
Ang-1 and VEGF: central regulators of angiogenesis
Y Zhao, B Yu, Y Wang, S Tan, Q Xu, Z Wang… - Molecular and Cellular …, 2024 - Springer
Abstract Angiopoietin-1 (Ang-1) and Vascular Endothelial Growth Factor (VEGF) are central
regulators of angiogenesis and are often inactivated in various cardiovascular diseases …
regulators of angiogenesis and are often inactivated in various cardiovascular diseases …
[HTML][HTML] Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer
The testicular androgen biosynthesis is well understood, however, how cancer cells gauge
dwindling androgen to dexterously initiate its de novo synthesis remained elusive. We …
dwindling androgen to dexterously initiate its de novo synthesis remained elusive. We …
[HTML][HTML] SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis
S Chouhan, D Sridaran, C Weimholt, J Luo, T Li… - Nature …, 2024 - nature.com
Mutations that decrease or increase the activity of the tyrosine phosphatase, SHP2 (encoded
by PTPN11), promotes developmental disorders and several malignancies by varying …
by PTPN11), promotes developmental disorders and several malignancies by varying …
[HTML][HTML] Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor
M Sawant, A Wilson, D Sridaran, K Mahajan… - Oncogene, 2023 - nature.com
Abstract Hormone receptor-positive, HER2-negative advanced breast cancers exhibit high
sensitivity to CDK4/6 inhibitors such as palbociclib. However, most patients inevitably …
sensitivity to CDK4/6 inhibitors such as palbociclib. However, most patients inevitably …
[HTML][HTML] Regulation, targets and functions of CSK
The Src family kinases (SFK) plays an important role in multiple signal transduction
pathways. Aberrant activation of SFKs leads to diseases such as cancer, blood disorders …
pathways. Aberrant activation of SFKs leads to diseases such as cancer, blood disorders …
[HTML][HTML] Dissection of the catalytic and regulatory structure-function relationships of Csk protein tyrosine kinase
G Sun, MK Ayrapetov - Frontiers in Cell and Developmental Biology, 2023 - frontiersin.org
Protein tyrosine kinases (PTKs) are a large enzyme family that regulates many cellular
processes. The key to their broad role in signaling is their tunable substrate specificity and …
processes. The key to their broad role in signaling is their tunable substrate specificity and …
Comprehensive Review on the Effect of Stem cells in Cancer Progression
Abstract Purpose of Review Adult stem cells play a pivotal role in the regeneration and
revival of tissues that have been affected by aging or injury. Emerging studies have provided …
revival of tissues that have been affected by aging or injury. Emerging studies have provided …
[HTML][HTML] Symptomatic benign prostatic hyperplasia with suppressed epigenetic regulator HOXB13 shows a lower incidence of prostate cancer development
NS Barashi, T Li, DH Angappulige, B Zhang… - Cancers, 2024 - mdpi.com
Simple Summary Patients with symptomatic Benign Prostatic Hyperplasia (BPH) showed
upregulated gene expression of biological pathways associated with T cell activation and …
upregulated gene expression of biological pathways associated with T cell activation and …
[HTML][HTML] Expanding horizons in overcoming therapeutic resistance in castration-resistant prostate cancer: targeting the androgen receptor-regulated tumor immune …
B Cheng, H Huang - Cancer Biology & Medicine, 2023 - ncbi.nlm.nih.gov
Castration-resistant prostate cancer (CRPC) poses a major treatment challenge, because
disease progression occurs despite androgen deprivation therapy (ADT) 1. Overcoming …
disease progression occurs despite androgen deprivation therapy (ADT) 1. Overcoming …